DOIAbstract
AbstractThis spring, Iain Mattaj will become the new Director General of the European Molecular Biology Laboratory (EMBL). Graham Tebb talks with him about his research career, his plans for his own future and that of the EMBL
AbstractThis spring, Iain Mattaj will become the new Director General of the European Molecular Biology Laboratory (EMBL). Graham Tebb talks with him about his research career, his plans for his own future and that of the EMBL
First Person is a series of interviews with the first authors of a selection of papers published in ...
AbstractMike Levine is at the University of California, Berkeley where he is co-Director of the newl...
AbstractThe Austrian Academy of Sciences has taken the bold step of closing a successful institute i...
AbstractThis spring, Iain Mattaj will become the new Director General of the European Molecular Biol...
AbstractKim Nasmyth is set to move from the Institute of Molecular Pathology in Vienna to take up a ...
AbstractStuart Schreiber is an Investigator at the Howard Hughes Medical Institute and Morris Loeb P...
AbstractHenry Bourne is Professor of Cellular and Molecular Pharmacology and Medicine at the Univers...
Graham Tebb reports on the appointment of the developmental neurobiologist, Barry Dickson, as the ne...
Günter Blobel was a scientific colossus who dedicated his career to understanding the mechanisms for...
I have had the pleasure of practicing biology and technology development for the past 35 yearssfirst...
Indexación: Scopus.I decided to do a second, 2-year postdoc in Phil Robbins’ lab at MIT. I applied f...
AbstractJonathan Hodgkin graduated from Oxford in 1971 and then did a PhD with Sydney Brenner at MRC...
GRAND FORKS, N.D.—Sergei Nechaev, PhD, assistant professor in the Department of Biomedical Sciences ...
Karl H. Jakobs, former editor-in-chief of Naunyn-Schmiedeberg's Archives of Pharmacology and renowne...
Mitchell received a bachelor's degree in molecular and computational biology and a master's degree i...
First Person is a series of interviews with the first authors of a selection of papers published in ...
AbstractMike Levine is at the University of California, Berkeley where he is co-Director of the newl...
AbstractThe Austrian Academy of Sciences has taken the bold step of closing a successful institute i...
AbstractThis spring, Iain Mattaj will become the new Director General of the European Molecular Biol...
AbstractKim Nasmyth is set to move from the Institute of Molecular Pathology in Vienna to take up a ...
AbstractStuart Schreiber is an Investigator at the Howard Hughes Medical Institute and Morris Loeb P...
AbstractHenry Bourne is Professor of Cellular and Molecular Pharmacology and Medicine at the Univers...
Graham Tebb reports on the appointment of the developmental neurobiologist, Barry Dickson, as the ne...
Günter Blobel was a scientific colossus who dedicated his career to understanding the mechanisms for...
I have had the pleasure of practicing biology and technology development for the past 35 yearssfirst...
Indexación: Scopus.I decided to do a second, 2-year postdoc in Phil Robbins’ lab at MIT. I applied f...
AbstractJonathan Hodgkin graduated from Oxford in 1971 and then did a PhD with Sydney Brenner at MRC...
GRAND FORKS, N.D.—Sergei Nechaev, PhD, assistant professor in the Department of Biomedical Sciences ...
Karl H. Jakobs, former editor-in-chief of Naunyn-Schmiedeberg's Archives of Pharmacology and renowne...
Mitchell received a bachelor's degree in molecular and computational biology and a master's degree i...
First Person is a series of interviews with the first authors of a selection of papers published in ...
AbstractMike Levine is at the University of California, Berkeley where he is co-Director of the newl...
AbstractThe Austrian Academy of Sciences has taken the bold step of closing a successful institute i...
Add to ORKG